Helga Raab
Genesys (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Cancer Treatment and Pharmacology, CAR-T cell therapy research, Click Chemistry and Applications
Most-Cited Works
- → Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index(2008)1,323 cited
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → Molecular cloning and expression of a receptor for human tumor necrosis factor(1990)967 cited
- → Identification of Heregulin, a Specific Activator of p185 erbB2(1992)963 cited
- → Novel antibody–antibiotic conjugate eliminates intracellular S. aureus(2015)820 cited
- → Site-specific antibody drug conjugates for cancer therapy(2013)650 cited
- → Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer(2010)290 cited
- → Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection(2009)248 cited
- → Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3(1995)209 cited
- → Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry(2011)189 cited